Apyx Medical (APYX) Reports Q4 Loss, Tops Revenue Estimates
Portfolio Pulse from
Apyx Medical (APYX) reported a Q4 loss of $0.12 per share, which was better than the Zacks Consensus Estimate of a $0.13 loss. This is an improvement from the $0.19 loss per share reported a year ago.
March 13, 2025 | 1:30 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Apyx Medical reported a Q4 loss of $0.12 per share, better than the expected $0.13 loss, and an improvement from last year's $0.19 loss.
The better-than-expected earnings report and improvement from the previous year suggest positive momentum for Apyx Medical. This could lead to a short-term positive impact on the stock price as investors react to the earnings beat.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100